Rights and permissions
About this article
Cite this article
Dolasetron preferable for antiemetic prophylaxis. Pharmacoecon. Outcomes News 276, 6 (2000). https://doi.org/10.1007/BF03267344
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03267344